ISSN Print 2713-2757
ISSN Online 2713-2765
SCIENTIFIC AND PRACTICAL REVIEWED JOURNAL OF FMBA OF RUSSIA
Deputy General Director for Research,
Federal Scientific and Clinical Center for Specialized Types of Medical Aid and Medical Technologies (Moscow, Russia)
DSc (medicine), professor
Areas of expertise:
regenerative medicine, stem cells, neurosciences, targeted drug delivery
Certificate of honor of the Mayor of Moscow (2020)
Certificate of honor of the Russian Academy of Science (2020)
Significant publications in last 5 years
1. Baklaushev VP, Durov OV, Kalsin VA, et al. Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates. World J Stem Cells 2021; 13(5): 452-469 DOI: 10.4252/wjsc.v13.i5.452 – Q2
2. Namestnikova DD, Gubskiy IL, Revkova VA, Sukhinich KK, Melnikov PA, Gabashvili AN, Cherkashova EA, Vishnevskiy DA, Kurilo VV, Burunova VV, Semkina AS, Abakumov MA, Gubsky LV, Chekhonin VP, Ahlfors J-E, Baklaushev VP, Yarygin KN Intra-Arterial Stem Cell Transplantation in Experimental Stroke in Rats: Real-Time MR Visualization of Transplanted Cells Starting With Their First Pass Through the Brain With Regard to the Therapeutic Action. Front Neurosci, 2021 Mar 2;15:641970. doi: 10.3389/fnins.2021.641970. eCollection 2021. – Q1
3. Revkova VA, Sidoruk KV, Kalsin VA <…> and Baklaushev VP. Spidroin Silk Fibers with Bioactive Motifs of Extracellular Proteins for Neural Tissue Engineering. ACS Omega. 2021 May 30;6(23):15264-15273. doi: 10.1021/acsomega.1c01576. PMID: 34151105; PMCID: PMC8210451. Q1
4. Byazrova M, Yusubalieva G, Spiridonova A, Efimov G, Mazurov D, Baranov K, Baklaushev V, Filatov A. Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19. Clin Transl Immunology. 2021 Jan 31;10(2):e1245. doi: 10.1002/cti2.1245. PMID: 33552508; PMCID: PMC7848539. Q1
5. Averyanov A, Koroleva I, Konoplyannikov M, Revkova V, Lesnyak V, Kalsin V, Danilevskaya O, Nikitin A, Sotnikova A, Kotova S, Baklaushev V. First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline. Stem Cells Transl Med. 2020 Jan;9(1):6-16. doi: 10.1002/sctm.19-0037.